Login / Signup

Safety and efficacy of apixaban versus warfarin in peritoneal dialysis patients with non-valvular atrial fibrillation: protocol for a prospective, randomised, open-label, blinded endpoint trial (APIDP2).

Maxence FicheuxLaure Peyro-Saint-PaulDorothée BalaynBlandine LecruxManon BrossierAntoine MorinAntoine LanotChloé PeronMarion BoulangerMarie BrionneFarzin BeyguiJean-Jacques ParientiThierry LobbedezC Béchade
Published in: BMJ open (2024)
ClinicalTrials.gov, NCT06045858; European Clinical Trial System, CT number 2023-507544-37-00.
Keyphrases